Salvatore Viscomi, M.D. is the CEO and co-founder of Carna Health, a digital health platform innovating CKD population screening, monitoring and care management by leveraging point-of-care testing and AI-driven software. He is also the chief strategy advisor of two healthcare startups, Dama Health and QuantaBrain and an executive advisor to Intellectual Digital, an investment firm based in NYC and London. He previously led a Harvard Stem Cell Institute company’s product line of genetic and biomarker testing.​ Dr. Viscomi is a practicing physician, instructor and an entrepreneur. He spent 14 years as a member of Harvard Medical School’s faculty and concurrently as a clinician at Brigham and Women’s Hospital. In that capacity, he held various administrative and clinical roles including Director of Admissions of a Harvard Residency Program and Department Chairman. As an expert in medical imaging, Dr. Viscomi has published and presented nationally and internationally. He co-founded Brigham NightWatch, one of the first teleradiology networks in the world. In addition, Dr. Viscomi served as an executive and board member of FreMon Scientific where he led the development of a next-generation blood product management solution through FDA approval and ultimately to market. Dr. Viscomi began his path toward medicine while at Columbia University, earning a B.A. in Neuropsychology. He completed his residency and specialization at Harvard Medical School. He also serves on the mission delivery committee of Make-A-Wish Foundation. In 2016, Dr. Viscomi completed the Executive Education Program at Harvard Business School.